Neurobiological Technologies, Inc.
NTIIOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$2702
P/E Ratio—
52W High$0.0001
52W Low$0.000001
Neurobiological Technologies, Inc.（NTII）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · NTII · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2009-06 | 2008-06 | 2007-06 | 2006-06 | 2005-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $26.35M | $14.76M | $17.67M | $12.34M | $3.10M |
| Cost of Revenue | $0.13M | $0.20M | $0.23M | $0.19M | $0.07M |
| Gross Profit | $26.22M | $14.55M | $17.44M | $12.14M | $3.03M |
| Gross Margin %(computed) | 99.50% | 98.61% | 98.70% | 98.43% | 97.67% |
| Operating Expenses | |||||
| R&D Expenses | $17.58M | $24.58M | $26.74M | $22.81M | $10.75M |
| G&A Expenses | $5.08M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $22.86M | $31.25M | $33.04M | $40.28M | $28.33M |
| Operating Income | $3.49M | ($16.70M) | ($15.60M) | ($27.94M) | ($25.23M) |
| Operating Margin %(computed) | 13.25% | -113.12% | -88.28% | -226.43% | -813.90% |
| Interest Income | $0.75M | $1.25M | $0.00M | $0.00M | $0.25M |
| Interest Expense | $0.00M | $2.48M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | $3.12M | ($16.32M) | ($14.13M) | ($27.54M) | ($25.23M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.30M | $0.00M |
| Net Income | $3.12M | ($16.32M) | ($14.13M) | ($27.84M) | ($24.98M) |
| Net Margin %(computed) | 11.85% | -110.58% | -79.94% | -225.62% | -805.86% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.12 | $-0.84 | $-3.26 | $-6.86 | $-6.58 |
| Wtd Avg Shares | 26.93M | 19.44M | 4.34M | 4.07M | 3.79M |
| EBITDA | $3.25M | ($16.49M) | ($15.37M) | ($16.24M) | ($12.48M) |
| EBITDA Margin %(computed) | 12.35% | -111.73% | -86.97% | -131.64% | -402.55% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Neurobiological Technologies, Inc.
关于Neurobiological Technologies, Inc.（NTII）损益表
Neurobiological Technologies, Inc.（NTII）损益表数据来源于SEC Form 10-K及10-Q申报文件。2009财年，NTII实现营收$0.03B，毛利润$0.03B（毛利率99.50%），净利润$0.00B（净利率11.85%）。
常见问题
NTII · 4 问Neurobiological Technologies, Inc.（NTII）2009财年营收为$0.03B，同比up78.5%。
NTII revenueNTII salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09